A phase 1 study of AR-42 in patients with advanced solid tumors, including nervous system tumors.

Author:

Valencia Hugo1,Newton Herbert B.1,Hade Erinn2,Sborov Douglas Weston1,Cavaliere Robert3,Poi Ming4,Phelps Mitch5,Wang Jiang6,Coss Christopher C5,Khountham Soun6,Monk Paul5,Olencki Thomas7,Shapiro Charles L6,Piekarz Richard8,Hofmeister Craig C.1,Grever Michael R.1,Welling D. Bradley9,Mortazavi Amir10

Affiliation:

1. Ohio State University, Columbus, OH;

2. The Ohio State University Center for Biostatistics, Columbus, OH;

3. The Ohio State Univ, Powell, OH;

4. The Ohio State Univ Med Ctr, Columbus, OH;

5. The Ohio State University, Columbus, OH;

6. The Ohio State University and The Comprehensive Cancer Center, Columbus, OH;

7. Ohio State University Medical Center, Columbus, OH;

8. Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Bethesda, MD;

9. Harvard Department of Otolaryngology, Boston, MA;

10. Arthur G. James Cancer Hospital, The Ohio State University Wexner Medical Center, Columbus, OH;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3